Hedegaard H, Miniño A, Warner M. Drug overdose deaths in the United States, 1999-2017. Hyattsville: National Center for Health Statistics; 2018.
Google Scholar
(CDC). Centers for Disease Prevention and Control. Rising numbers of deaths involving fentanyl and fentanyl analogs, including carfentanil, and increased usage and mixing with non-opioids 2018. Available from: https://emergency.cdc.gov/han/HAN00413.asp. Access date: March 7, 2019
Jones CM, Einstein EB, Compton WM. Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010-2016. JAMA. 2018;319(17):1819–21.
Article
Google Scholar
(NIDA). National Institute on Drug Abuse. Overdose death rates 2018. Available from: https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates Access date: March 10, 2019.
Sanger-Katz M. "Bleak new estimates in drug epidemic: a record 72,000 overdose deaths in 2017." The New York Times, Aug. 15, 2018. Available at: https://www.nytimes.com/2018/08/15/upshot/opioids-overdose-deaths-rising-fentanyl.html. Accessed 10 Mar 2019.
Maryland Department of Health. Unintentional drug- and alcohol-related intoxication deaths in Maryland Annual Report. 2017.
Marshall BDL, Krieger MS, Yedinak JL, Ogera P, Banerjee P, Alexander-Scott NE, et al. Epidemiology of fentanyl-involved drug overdose deaths: a geospatial retrospective study in Rhode Island, USA. Int J Drug Policy. 2017;46:130–135.
Article
Google Scholar
Massachusetts Department of Public Health. Data Brief: Opioid-related overdose deaths among Massachussetts residents, May 2018. Boston, MA; 2018 2018. Available at: https://www.mass.gov/files/documents/2018/05/22/Opioid-related%20Overdose%20Deaths%20among%20MA%20Residents%20-%20May%202018.pdf .Accessed 15 Feb 2019.
Rhode Island Department of Health. Overdose death data 2018. Available from: https://preventoverdoseri.org/overdose-deaths/. Accessed 1 Mar 2019.
Amlani A, McKee G, Khamis N, Raghukumar G, Tsang E, Buxton JAJHRJ. Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada. Harm Reduction J. 2015;12(1):54.
Park JN, Weir BW, Allen ST, Chaulk P, Sherman SG. Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD. Harm Reduction J. 2018;15(1):34.
Article
Google Scholar
Ciccarone D. Fentanyl in the US heroin supply: a rapidly changing risk environment. Int J Drug Policy. 2017;46:107–11.
Article
Google Scholar
McGowan CR, Harris M, Platt L, Hope V, Rhodes T. Fentanyl self-testing outside supervised injection settings to prevent opioid overdose: do we know enough to promote it? Int J Drug Policy. 2018;58:31–6.
Article
Google Scholar
Clark AK, Wilder CM, Winstanley EL. A systematic review of community opioid overdose prevention and naloxone distribution programs. J Addict Med. 2014;8(3):153–63.
Article
CAS
Google Scholar
Lagu T, Anderson BJ, Stein M. Overdoses among friends: drug users are willing to administer naloxone to others. J Subst Abus Treat. 2006;30(2):129–33.
Article
Google Scholar
Bagley SM, Forman LS, Ruiz S, Cranston K, Walley AY. Expanding access to naloxone for family members: The Massachusetts experience. Drug Alcohol Rev. 2018;37(4):480–6.
Article
Google Scholar
Barratt MJ, Bruno R, Ezard N, Ritter A. Pill testing or drug checking in Australia: acceptability of service design features. Drug Alcohol Rev. 2018;37(2):226–36.
Article
Google Scholar
Butterfield RJ, Barratt MJ, Ezard N, Day RO. Drug checking to improve monitoring of new psychoactive substances in Australia. Med J Aust. 2016;204(4):144–5.
Article
Google Scholar
Decorte T. Quality control by cocaine users: underdeveloped harm reduction strategies. Eur Addict Res. 2001;7(4):161–75.
Article
CAS
Google Scholar
Gine CV, Vilamala MV, Measham F, Brunt TM, Bucheli A, Paulos C, et al. The utility of drug checking services as monitoring tools and more: a response to Pirona et al. Int J Drug Policy. 2017;45:46–7.
Article
Google Scholar
Hungerbuehler I, Buecheli A, Schaub MJHRJ. Drug Checking: a prevention measure for a heterogeneous group with high consumption frequency and polydrug use - evaluation of zurich's drug checking services. 2011;8(1):16.
Mounteney J, Griffiths P, Sedefov R, Noor A, Vicente J, Simon R. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015. Addiction. 2016;111(1):34–48.
Article
Google Scholar
Saleemi S, Pennybaker SJ, Wooldridge M, Johnson MW. Who is ‘Molly’? MDMA adulterants by product name and the impact of harm-reduction services at raves. J Psychopharmacol. 2017;31(8):1056–60.
Article
CAS
Google Scholar
Sande M, Šabić S. The importance of drug checking outside the context of nightlife in Slovenia. Harm Reduction J. 2018;15(1):2.
Article
Google Scholar
Brunt T. Drug checking as a harm reduction tool for recreational drug users: opportunities and challenges. European Monitoring Centre for Drugs and Drug Addiction; 2017.
Google Scholar
Laing MK, Tupper KW, Fairbairn N. Drug checking as a potential strategic overdose response in the fentanyl era. Int J Drug Policy. 2018;62:59–66.
Article
Google Scholar
Sherman SGPJ, Glick J, et al. FORECAST Study Summary Report: Johns Hopkins Bloomberg School of Public Health; 2018.
Glick JL, Christensen T, Nyeong Park J, McKenzie M, Green TC, Sherman SG. Stakeholder perspectives on implementing fentanyl drug checking: results from a multi-site study. Drug and Alcohol Dependence. 2019(1879–0046 (Electronic)).
Peiper NC, Clarke SD, Vincent LB, Ciccarone D, Kral AH, Zibbell JE. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. Int J Drug Policy. 2018;63:122–128.
Article
Google Scholar
Dickson-Gomez J. Can drug users be effective change agents? Yes, but much still needs to change. Subst Use Misuse. 2010;45(1-2):154–60.
Article
Google Scholar
Mars SG, Ondocsin J, Ciccarone D. Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency. Harm Reduction J. 2018;15(1):26.
Article
Google Scholar
McCance-Katz E. 2018. Available from: https://blog.samhsa.gov/2018/10/03/for-beating-the-opioid-crisis-america-has-better-weapons-than-fentanyl-test-strips. Accessed 1 Feb 2019.
Green TC PJ, Gilbert M et al. A multi-site assessment of the limites of detection, sensitivity and specificity of three devices for public health-based druch checking of fentanyl in street-acquired samples. Under Review. 2019.
Google Scholar
Sherman SG MK, Park JN, et al. Feasibility of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence. 2019.
Google Scholar
Allen ST, Footer KHA, Galai N, Park JN, Silberzahn B, Sherman SG. Implementing targeted sampling: lessons learned from recruiting female sex workers in Baltimore, MD. J Urban Health. 2018.
Carroll JJ, Marshall BDL, Rich JD, Green TC. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: a mixed methods study. Int J Drug Policy. 2017;46:136–45.
Article
Google Scholar
Williams CT, Metzger DS. Race and distance effects on regular syringe exchange program use and injection risks: a geobehavioral analysis. Am J Public Health. 2010;100(6):1068–74.
Article
Google Scholar
Watters JK, Estilo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA. 1994;271(2):115–20.
Article
CAS
Google Scholar
Martins SS, Santaella-Tenorio J, Marshall BDL, Maldonado A, Cerdá M. Racial/ethnic differences in trends in heroin use and heroin-related risk behaviors among nonmedical prescription opioid users. Drug Alcohol Depend. 2015;151:278–83.
Article
Google Scholar
Novak SP, Bluthenthal R, Wenger L, Chu D, Kral AH. Initiation of heroin and prescription opioid pain relievers by birth cohort. Am J Public Health. 2016;106(2):298–300.
Article
Google Scholar
SAMSHA. Opioid Overdose Prevention Toolkit 2018.
Frank D, Mateu-Gelabert P, Guarino H, Bennett A, Wendel T, Jessell L, et al. High risk and little knowledge: overdose experiences and knowledge among young adult nonmedical prescription opioid users. Int J Drug Policy. 2015;26(1):84–91.
Article
Google Scholar
Marshall BDL, Green TC, Yedinak JL, Hadland SE. Harm reduction for young people who use prescription opioids extra-medically: obstacles and opportunities. Int J Drug Policy. 2016;31:25–31.
Article
Google Scholar
Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2005;61(5):1026–44.
Article
Google Scholar
Rhodes T, Stimson Gv Fau - Crofts N, Crofts N Fau - Ball A, Ball A Fau - Dehne K, Dehne K Fau - Khodakevich L, Khodakevich L. Drug injecting, rapid HIV spread, and the 'risk environment': implications for assessment and response. AIDS 1999(0269-9370 (Print)):S259-69.
Latkin CA, Edwards C, Davey-Rothwell MA, Yang C, Tobin KE. The relationship between drug use settings, roles in the drug economy, and witnessing a drug overdose in Baltimore, Maryland. Subst Abus. 2018;39(3):384–9.
Article
Google Scholar
Martins SS, Sampson L, Cerdá M, Galea S. Worldwide prevalence and trends in unintentional drug overdose: a systematic review of the literature. 2015;105(11):e29–e49.
Coffin PO, Tracy M, Bucciarelli A, Ompad D, Vlahov D, Galea S. Identifying injection drug users at risk of nonfatal overdose. Acad Emerg Med. 2007;14(7):616–23.
Article
Google Scholar
Des Jarlais DC, Arasteh K, Perlis T, Hagan H, Heckathorn DD, McKnight C, et al. The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City. Addiction. 2007;102(5):778–85.
Article
Google Scholar
Drug Policy Alliance. Report: Drug Checking 2019. Available from: http://www.drugpolicy.org/issues/drug-checking. Accessed 27 Feb 2019.
Khazan O. The $1 tool that might curb the overdose epidemic. The Atlantic. 2018.
North Carolina Journal of Law and Technology. "Fentanyl test kits save lives – but still illegal in N.C." Available from: http://ncjolt.org/fentanyl-test-kits-save-lives-but-still-illegal-in-n-c/. Accessed 8 May 2019.
Tosheff T. Fentanyl test strips considered drug paraphernalia in Pennsylvania: ABC27 News; 2019. Available from: https://www.abc27.com/news/local/fentanyl-test-strips-considered-drug-paraphernalia-in-pennsylvania/1832067763. Accessed 8 May 2019.
Arizona Revised Statutes, Section 13-3415.
North Carolina Drug Paraphernalia Act (c. 500, s. 1.), (1981).
Illinois Compiled Statues: Drug Paraphernalia Control ACT ILCS 600. 2016.
Bardwell G, Boyd J, Arredondo J, McNeil R, Kerr T. Trusting the source: the potential role of drug dealers in reducing drug-related harms via drug checking. Drug Alcohol Depend. 2019;198:1–6.
Article
Google Scholar
Wines JD, Saitz R, Horton NJ, Lloyd-Travaglini C, Samet JH. Overdose after detoxification: a prospective study. Drug Alcohol Depend. 2007;89(2):161–9.
Article
Google Scholar
Ghanem KG, Hutton HE, Zenilman JM, Zimba R, Erbelding EJ. Audio computer assisted self interview and face to face interview modes in assessing response bias among STD clinic patients. Sex Transm Infect. 2005;81(5):421.
Article
CAS
Google Scholar
Brown JL, Swartzendruber A, DiClemente RJ. Application of audio computer-assisted self-interviews to collect self-reported health data: an overview. Caries Res 2013;47 Suppl 1(0 1):40–45.
Article
Google Scholar
Kerr T, Small W, Hyshka E, Maher L, Shannon K. It’s more about the heroin’: injection drug users’ response to an overdose warning campaign in a Canadian setting. Addiction (Abingdon, England). 2013;108(7):1270–6.
Article
Google Scholar
Miller PG. Media reports of heroin overdose spates: public health messages, moral panics or risk advertisements? Critical Public Health. 2007;17(2):113–21.
Article
Google Scholar
(DEA) USDEA. National Drug Threat Assessment 2018. Available from: https://www.dea.gov/sites/default/files/2018-11/DIR-032-18%202018%20NDTA%20final%20low%20resolution.pdf. Accessed 10 May 2019.